Background: Although diabetes mellitus is a well-researched systemic endocrinal disease, literature is scarce addressing the co-occurrence of oropharyngeal dysphagia with diabetes. Objective: The aim of this work was to screen Egyptian diabetic patients for symptoms suggestive of oropharyngeal dysphagia using the validated Arabic version of the Eating Assessment Tool (A-EAT-10). Participants and Methods: 200 Egyptian adult diabetic patients, aged from 18 to 59 years participated in the study. The inclusion criteria were being diabetic patients of type 1 or type 2. Patients were asked to complete the A-EAT-10 questionnaire. Results: Age progression and being female were found to be risk factors for dysphagia among diabetic patients participating in this study. The most common symptom among diabetic patients who complained of dysphagia was “I cough when I eat.” Conclusion: The present study suggests the presence of oropharyngeal swallowing problems among patients with diabetes mellitus.

1.
Feldman
EL
,
Nave
KA
,
Jensen
TS
,
Bennett
DL
.
New horizons in diabetic neuropathy: Mechanisms, bioenergetics and pain
.
Neuron
.
2017
Mar
;
93
(
6
):
1296
313
.
[PubMed]
0896-6273
2.
Farahat
M
,
Mesallam
TA
.
Validation and cultural adaptation of the Arabic version of the Eating Assessment Tool (EAT-10)
.
Folia Phoniatr Logop
.
2015
;
67
(
5
):
231
7
.
[PubMed]
1021-7762
3.
Rosztóczy
A
,
Róka
R
,
Várkonyi
TT
,
Lengyel
C
,
Izbéki
F
,
Lonovics
J
, et al.
Regional differences in the manifestation of gastrointestinal motor disorders in type 1 diabetic patients with autonomic neuropathy
.
Z Gastroenterol
.
2004
Nov
;
42
(
11
):
1295
300
.
[PubMed]
0044-2771
4.
Restivo
DA
,
Marchese-Ragona
R
,
Lauria
G
,
Squatrito
S
,
Gullo
D
,
Vigneri
R
.
Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy
.
Diabetes Care
.
2006
Dec
;
29
(
12
):
2650
3
.
[PubMed]
0149-5992
5.
Belafsky
PC
,
Mouadeb
DA
,
Rees
CJ
,
Pryor
JC
,
Postma
GN
,
Allen
J
, et al.
Validity and reliability of the Eating Assessment Tool (EAT-10)
.
Ann Otol Rhinol Laryngol
.
2008
Dec
;
117
(
12
):
919
24
.
[PubMed]
0003-4894
6.
Rofes
L
,
Arreola
V
,
Mukherjee
R
,
Clavé
P
.
Sensitivity and specificity of the Eating Assessment Tool and the Volume-Viscosity Swallow Test for clinical evaluation of oropharyngeal dysphagia
.
Neurogastroenterol Motil
.
2014
Sep
;
26
(
9
):
1256
65
.
[PubMed]
1350-1925
7.
Mendell
DA
,
Logemann
JA
.
A retrospective analysis of the pharyngeal swallow in patients with a clinical diagnosis of GERD compared with normal controls: a pilot study
.
Dysphagia
.
2002
;
17
(
3
):
220
6
.
[PubMed]
0179-051X
8.
Borgström
PS
,
Olsson
R
,
Sundkvist
G
,
Ekberg
O
.
Pharyngeal and oesophageal function in patients with diabetes mellitus and swallowing complaints
.
Br J Radiol
.
1988
Sep
;
61
(
729
):
817
21
.
[PubMed]
0007-1285
9.
Hammersjö
R
,
Roth
B
,
Höglund
P
,
Ohlsson
B
:
Esophageal and Gastric Dysmotilities are Associated with Altered Glucose Homeostasis and Plasma Levels of Incretins and Leptin.
Review of diabetic studies Journal,
2016
, 13:79-90
10.
Boolkin
L
.
The incidence of dysphagia in diabetic patients
(Doctoral dissertation). Wits Institutional Repository (WIReDSpace).
2016
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.